Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Comment by fredgoodwinsonon Jan 02, 2020 8:42am
114 Views
Post# 30510321

RE:Here we go again

RE:Here we go againThe way I look at it silver it will be very difficult - IND or not,bureaucrat or otherwise - for the sp to find itself in the same place in 6 months` time.IMHO 2020 will be the definitive year for TLT. 

At least five patients - and probably a few more - will have received their second treatment by the middle of the year.For those of us who think that the great majority of patients will need only one course of therapy the real excitement is contained in Eoganacht`s recent post concerning the potential for PDT to systemically overwhelm a cancer remote to the treatment site.

It has never been reported and do not take this as fact but anecdotally it has been implied by posters here who have attended an AGM and held informal conversations there that this may have occurred preclinically with a second round of PDT.

If so the potential implications for the future treatment of many cancers will be profound.


Bullboard Posts